Latest other current liabilities for AGN: $7B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Allergan plc (AGN) currently reports a other current liabilities of $7B as of March 2020. That compares with $8.5B in the prior-year period — down 17.2% year over year. Use the charts on this page to explore Allergan plc's other current liabilities history and peer comparisons.
Allergan plc's other current liabilities decreased from $8.5B to $7B — a 17.2% year-over-year decrease (period ending March 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Allergan plc reported $7B in other current liabilities as of March 2020. That compares with $8.5B in the prior-year period — down 17.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current liabilities of $7B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Allergan plc, and consider following AGN for alerts when major investors trade the stock.
Allergan plc is classified in the Healthcare sector. On other current liabilities, it currently shows $7B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGN with unrelated industries.